Humana Inc. vs Samsung Electronics Co., Ltd.: Strategic Comparison

This in-depth comparison examines Humana Inc. and Samsung Electronics Co., Ltd. across revenue, market value, business model, competitive positioning, and long-term growth strategy. Whether you are researching Humana Inc. on its own, evaluating Samsung Electronics Co., Ltd., or weighing the two companies side by side, the breakdown below highlights where each company leads and where the gap between Humana Inc. and Samsung Electronics Co., Ltd. is widest.

On the headline numbers, Humana Inc. reports annual revenue of $129.7B against ~$236.9B for Samsung Electronics Co., Ltd., while their respective market capitalizations stand at $48.2B and $1.33T. Humana Inc. is headquartered in United States and Samsung Electronics Co., Ltd. in South Korea, and those different home markets shape how each company competes.

Humana Inc.: Humana Inc. is a Fortune 50 health company headquartered in Louisville, Kentucky. It serves roughly 7.2 million individual and group Medicare Advantage members, millions of stand-alone Part D, Medicaid, and TRICARE beneficiaries, and patients of its CenterWell clinics, pharmacy, and home health services. Unlike diversified rivals, Humana gets nearly all of its medical membership from government-funded programs, so it is effectively a bet on Medicare Advantage and senior care.

Samsung Electronics Co., Ltd.: Samsung Electronics, based in Suwon, is the flagship company of the Samsung Group and South Korea's most valuable listed company. It is the world's largest memory chipmaker and one of the two largest smartphone vendors. Its market value passed $1 trillion in May 2026 and was about $1.33 trillion in late September 2026, after its shares more than tripled in a year on AI memory demand. The company is led by co-CEOs Jun Young-hyun (semiconductors) and TM Roh (devices), with Jay Y. Lee as Executive Chairman.

Humana Inc. and Samsung Electronics Co., Ltd. pursue distinct approaches to generating revenue, and understanding how each company operates is the foundation of any fair comparison between Humana Inc. and Samsung Electronics Co., Ltd..

Humana Inc. business model: Humana runs two reporting segments. The Insurance segment sells individual and group Medicare Advantage plans, stand-alone Medicare Part D drug plans, state Medicaid contracts, and administers TRICARE for the Defense Health Agency. It is paid largely by the federal government on a per-member, per-month basis adjusted for each member's health risk, and keeps the difference between those premiums and medical and pharmacy claims plus operating costs. The CenterWell segment provides services: CenterWell Senior Primary Care clinics, CenterWell Pharmacy (mail-order and specialty), and CenterWell Home Health. CenterWell serves Humana members and members of other plans, and it gives Humana direct influence over care costs for its own seniors.

Samsung Electronics Co., Ltd. business model: Samsung earns money from two groups of businesses. Device Solutions (DS) makes and sells memory (DRAM, HBM, NAND), System LSI chips such as Exynos processors and ISOCELL image sensors, and contract foundry manufacturing. In Q2 2026, DS produced ~$90.5 billion (KRW 127.5 trillion) of the company's ~$122 billion (KRW 171.5 trillion) revenue and ~$63.3 billion (KRW 89.2 trillion) of its ~$63.5 billion (KRW 89.5 trillion) operating profit. Device eXperience (DX) sells Galaxy phones, tablets, wearables, TVs, monitors and home appliances, plus network equipment. Separately consolidated subsidiaries add OLED panels from Samsung Display, sold to Apple and other phone makers, and automotive and audio electronics from Harman.

The durability of a company's moat often decides long-term winners. Here is how the competitive advantages of Humana Inc. stack up against those of Samsung Electronics Co., Ltd..

Humana Inc. competitive advantage: Humana's edge is depth in one market. It is the second-largest Medicare Advantage insurer after UnitedHealth, it has decades of experience pricing senior risk, and it owns care-delivery assets built for seniors: CenterWell Senior Primary Care clinics, a large mail-order pharmacy, and CenterWell Home Health. Owning those services lets Humana manage chronic conditions and pharmacy spending directly instead of only paying claims. The tradeoff is concentration: unlike UnitedHealth, CVS/Aetna, or Elevance, it has no large commercial or PBM business to offset a bad Medicare year.

Samsung Electronics Co., Ltd. competitive advantage: Samsung's edge is manufacturing scale and breadth. It is the largest memory producer and one of only three major DRAM makers, alongside SK hynix and Micron. That lets it capture pricing upswings like the 2026 AI-driven shortage. It also owns component businesses (memory, OLED through Samsung Display, image sensors) that sell to rivals as well as to its own Galaxy devices, so it earns money even when competitors' products win.

Future prospects matter as much as current results. The growth strategies below explain how Humana Inc. and Samsung Electronics Co., Ltd. each plan to expand from here.

Humana Inc. growth strategy: Humana's strategy under Jim Rechtin is to grow Medicare Advantage membership while rebuilding margins and quality scores. Key moves include completing the exit from employer-group commercial medical coverage in 2025, adding more than 1 million MA members for 2026, pruning about 600,000 members' worth of underperforming plans for 2027, investing in Star Ratings operations, and expanding CenterWell Senior Primary Care and CenterWell Pharmacy so that more member care runs through Humana-owned services. It is also bidding for and growing state Medicaid contracts, with a focus on members eligible for both Medicare and Medicaid.

Samsung Electronics Co., Ltd. growth strategy: Samsung's growth plan centers on AI memory: ramping HBM4 for Nvidia and AMD accelerators, developing HBM4E, and adding DRAM capacity at Pyeongtaek. In foundry it is pursuing 2nm gate-all-around production and building its Taylor, Texas fab to win customers from TSMC. On the device side it relies on Galaxy AI features, foldables and premium TVs to defend share against Apple and Chinese brands.

A closer look at the financial trajectory of Humana Inc. and Samsung Electronics Co., Ltd. rounds out the comparison.

Humana Inc.: Humana's revenue grew from $54.4 billion in 2016 to $129.66 billion in 2025, driven by Medicare Advantage enrollment and higher per-member payments. Profit moved the other way: net income fell from $3.37 billion in 2020 to $1.21 billion in 2024 and $1.19 billion in 2025 as medical costs rose faster than payments. In 2026 revenue is growing fast again: Q2 2026 revenue was $40.89 billion, up 26.2% year over year, with GAAP EPS of $5.73 and adjusted EPS of $7.61. Year-to-date operating cash flow reached $3.22 billion. Full-year 2026 guidance is adjusted EPS of at least $9.00 and GAAP EPS of at least $6.52, reflecting the Star Ratings bonus headwind.

Samsung Electronics Co., Ltd.: Samsung's earnings follow the memory cycle. Revenue fell from ~$215 billion (KRW 302.2 trillion) in 2022 to ~$184 billion (KRW 258.9 trillion) in 2023 during a chip downturn, then recovered to ~$214 billion (KRW 300.9 trillion) in 2024 and ~$237 billion (KRW 333.6 trillion) in 2025, when net income reached about $31.5 billion (KRW 44.3 trillion). In 2026, AI server demand created a memory shortage. Q1 operating profit of ~$40.6 billion (KRW 57.2 trillion) exceeded the full-year 2025 total, and Q2 reached ~$63.5 billion (KRW 89.5 trillion) on ~$122 billion (KRW 171.5 trillion) revenue. Higher memory costs also squeezed Samsung's own devices: the MX and Networks unit lost ~$497 million (KRW 0.7 trillion) in Q2 2026 on ~$23.6 billion (KRW 33.2 trillion) revenue.